Skip to main content
Equibles

TAK · Takeda Pharmaceutical Co Ltd · Documents

Track TAK — free

Use TAK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TAK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$19.76 +0.09 (+0.46%)
Rebalance outlook locked
Market Cap
$62.84B
Shares
3.19B
Volume · Oct 16 2.83M Avg daily vol (3M) 2.97M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
Type AI summary Filing Date Period Open
6-K — 2026-09-14 —
6-K — 2026-08-31 2026-08-28
6-K — 2026-08-06 2026-08-05
6-K — 2026-07-30 —
6-K — 2026-07-09 —
6-K — 2026-07-08 —
6-K — 2026-06-29 —
6-K — 2026-06-26 —
6-K — 2026-06-24 —
6-K — 2026-06-24 —
6-K — 2026-06-24 —
20-F — 2026-06-17 2026-03-31
6-K — 2026-06-09 —
6-K — 2026-06-05 —
6-K — 2026-06-05 —
6-K — 2026-06-01 —
6-K — 2026-05-26 —
6-K — 2026-05-26 —
6-K — 2026-05-26 —
6-K — 2026-05-26 —
6-K — 2026-05-26 —
6-K — 2026-05-19 —
6-K — 2026-05-13 —
6-K — 2026-05-13 —
6-K — 2026-03-30 —
6-K — 2026-03-26 —
6-K — 2026-03-25 —
6-K — 2026-03-02 —
6-K — 2026-02-10 —
6-K — 2026-01-29 —
6-K — 2025-12-18 —
6-K — 2025-12-08 —
6-K — 2025-11-28 —
6-K — 2025-10-30 —
6-K — 2025-10-30 —
6-K — 2025-10-30 —
6-K — 2025-10-01 —
6-K — 2025-09-25 —
6-K — 2025-09-08 —
6-K — 2025-07-31 —
6-K — 2025-07-30 —
6-K — 2025-07-14 —
6-K — 2025-07-09 —
6-K — 2025-07-08 —
6-K — 2025-07-02 —
6-K — 2025-07-01 —
6-K — 2025-06-30 —
6-K — 2025-06-25 —
20-F — 2025-06-25 2025-03-31
6-K — 2025-06-25 —
Showing 1–50 of 311 filings
Key facts CIK 1395064 CUSIP 874060205 13F (30d) 59 filings 44 filers Visit website Investor relations